Repurposing of HIV/HCV protease inhibitors against SARS-CoV-2 3CL(pro)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen that caused the global COVID-19 outbreak. The 3C-like protease (3CL(pro)) of SARS-CoV-2 plays a key role in virus replication and has become an ideal target for antiviral drug design. In this work, we have employed biolumin...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Ling, Li, Quanjie, Xie, Yongli, jianyuan Zhao, Yi, Dongrong, Guo, Saisai, Guo, Fei, Wang, Jing, Yang, Long, Cen, Shan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499987/
https://www.ncbi.nlm.nih.gov/pubmed/36155070
http://dx.doi.org/10.1016/j.antiviral.2022.105419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9499987/
https://www.ncbi.nlm.nih.gov/pubmed/36155070
http://dx.doi.org/10.1016/j.antiviral.2022.105419

Ejemplares similares